Page 92 - Fertility in Women with Rheumatoid Arthritis Vruchtbaarheid van vrouwen met reumatoïde artritis

Chapter 6
Table 1 - Baseline characteristics
Variable
Age - years (mean ± sd)
at start trying to conceive at study visit
Previous pregnancies (n (%)) 0
1
2
3 or more
Previous miscarriages (n (%)) 0
1
2 or more
Disease characteristics
Duration of RA - years (median (IQR)) at start trying to conceive
at study visit
missing
RF positive (n (%)) missing
ACPA positive (n (%))
Presence of erosions (patient) (n (%))
missing
DAS28-CRP at study visit (mean ± sd)
missing
Anti-rheumatic drugs use at time of study visit* (n (%))
None
Prednisone
Sulfasalazine Hydroxychloroquine
NSAIDs (incl COX2 inhibitors) Biologics
Ever used MTX (n (%)) missing
Preconceptional n=209
31.7 ± 3.9 32.1 ± 3.9
110 (53%) 67 (32%) 25 (12%) 7 (3.4%)
181 (87%) 20 (9.6%) 8 (3.8%)
4.1 (1.7 - 9.0) 4.5 (2.0 - 9.4) 2 (1.0%) 153 (73%) 2 (1.0%) 137 (66%) 107 (51%) 41 (20%) 3.73 ± 1.17 3 (1.4%)
19 (9.1%) 89 (43%) 76 (36%) 16 (7.7%) 94 (45%) 8 (3.8%) 148 (71%) 1 (0.5%)
RA = rheumatoid arthritis, RF = rheumatoid factor, ACPA = anti-citrullinated protein antibody, DAS28-CRP = disease activity score using a 28 joint count and C-reactive protein, NSAIDs= non-steroidal anti-inflammatory drugs, COX2 = cyclo-oxygenase 2;
* When using anti-rheumatic drugs, patients could be using more than 1 of the reported drugs.
90